Novo Nordisk Research & Development - Who we are
Novo Nordisk is a focused healthcare company with a leading position within haemostasis management, growth hormone therapy and hormone replacement therapy.
Being part of Novo Nordisk Research & Development means working at one of the world’s largest biopharmaceutical company.
As the global leader in diabetes care, millions of patients worldwide rely on us to deliver cutting-edge treatments for their chronic disease every day. Additionally, we continue to invest in developing innovative treatments for obesity, haemophilia, growth disorders, and inflammation.
Our success is built on more than 90 years of innovation and commitment to patients. We combine world-class scientific, pharmaceutical, and clinical expertise with the highest ethical standards to continue to improve the quality of life for our patients.
Our Research & Development organisation is vital to Novo Nordisk's continued growth and we offer an inspiring and ambitious work environment with highly dedicated colleagues. Therefore, we welcome talented people who would like to grow with us.
Life-changing career opportunities
From molecule to market, our focus is always the patient when developing best-in-class treat-ments. Long-term thinking drives all our activities and we continuously demonstrate our com-mitment to environmental and social responsibility. We believe this is one of the things that sets us apart from other pharmaceutical companies.
Working at Novo Nordisk Research & Development is a mutually rewarding commitment. Our consistent growth provides you with professional development and career opportunities – as well as ample funding for projects. Thus, we invite you to bring your personal ambition and passion to work and take tomorrow’s research and clinical development to the next level.
We trust in each individual's sense of responsibility and commitment to deliver excellent results and offer a flexible working environment. We have the culture of ingenuity needed to develop the next generation of life-saving therapies. Therefore, you will be part of a highly dedicated team, in which everyone inspires each other in the mutual aspiration to further improve the lives of millions of people requiring chronic care.
Meet Novo Nordisk researchers
Working towards the next break-through
Innovation combined with the best protein science and unrelenting hard work are at the heart of the success of the R&D organisation at Novo Nordisk. Individual scientists and research developers are driven by a combination of professional curiosity, human compassion and the desire to turn scientific discovery into real-life solutions to address unmet treatment needs. If you would like to join us in working towards the next therapeutic breakthrough and embarking on a career with the potential to change peoples' lives, please visit our R&D career site.
At Novo Nordisk, we have innovated therapeutic proteins for almost 90 years – and we are still counting.
Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
Headquartered in Denmark, Novo Nordisk employs more than 40,000 employees in 75 countries, and markets its products in more than 180 countries.
Approximately 5000 ambitious people work at our global Research and Development sites in Denmark, USA, China and India. And in addition more than 1,000 employees work in clinical development centres around the world.
This number is expected to grow significantly in the coming years due to continuous expansion of our Research and Development activities.
The Triple Bottom Line is the principle that guides Novo Nordisk's way of working. It sets the foundation for long-term growth and drives our commitment to meet the needs of the present without compromising the ability of future generations to meet their needs. In day-to-day practice, this implies that all decisions must seek to balance three considerations: Is it economically viable? Is it socially responsible? Is it environmentally sound? This is the Triple Bottom Line, which ensures that decision-making balances financial growth with corporate responsibility, short-term gains with long-term growth, and shareholder return with other stakeholders.
Take the next step
Novo Nordisk hire more than 600 people within R&D a year. See the current vacant positions and sign up for the email job agent at the R&D Career site.